02.06.2013 Views

PRINCIPLES OF TOXICOLOGY

PRINCIPLES OF TOXICOLOGY

PRINCIPLES OF TOXICOLOGY

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

10.5 TESTS FOR DETECTING IMMUNOTOXICITY IN ANIMAL MODELS 197<br />

normally produces cellular proliferation and increased immunoglobulin synthesis. This response<br />

requires both TH and B cells, and provides an indication of the capability of these two cells to interact<br />

properly and of B cells to produce immunoglobulins. Lipopolysaccharide (LPS) is a mitogen effective<br />

selectively on B cells, while phytohemaglutinin (PHA) and concanavalin A (con A) are selective T-cell<br />

mitogens. Other stimulants to lymphocyte activation can be used, such as tetanus toxoid, diptheria<br />

toxoid, Candida, and PPD, if the subject has been previously exposed to these. The rapid cell division<br />

characteristic of a normal response to these mitogens is typically assessed by measuring incorporation<br />

of 3 H-thymidine into DNA of the cells. Other endpoints of stimulation, such as increased expression<br />

of IL2 receptors on T cells, can also be evaluated. The results of these tests are particularly prone to<br />

variability, and the tests should be repeated on several occasions in order to demonstrate an abnormal<br />

response.<br />

In the mixed-lymphocyte reaction (MLR) test, lymphocytes from the test subject and another<br />

individual are mixed. Normally, contact with the allogenic lymphocytes will cause the test subject’s<br />

lymphocytes to become activated and proliferate. To conduct this assay, the target lymphocytes are<br />

rendered incapable of replication, often by irradiation or by treatment with mitomycin C. Test subject<br />

lymphocytes are then added, and the rate of their replication is evaluated by measuring incorporation<br />

of 3 H-thymidine. The cytotoxic lymphocyte (CTL) assay takes the lymphocyte interactions one step<br />

further to evaluate the ability of cytotoxic T cells (T C ) to destroy target cells. After incubation of the<br />

test subject and target lymphocytes, the subject T C are isolated, washed, and reincubated with target<br />

lymphocytes preloaded with 51 Cr. As the target cells are destroyed, 51 Cr is released into the medium<br />

and can be measured, providing an index of cytotoxic capabilities of the T C lymphocytes.<br />

Fluorescent Antinuclear Antibody Assay (FANA) The indirect immunofluorescence antinuclear<br />

antibody assay (FANA) may be the initial screening test used to show autoimmunity. However, several<br />

FANA patterns are recognized in various connective-tissue diseases and some low-titer staining<br />

patterns have also been reported in sera from persons exposed to environmental agents. The following<br />

staining patterns may be observed:<br />

1. The diffuse (homogenous) staining pattern, which is usually associated with antibody directed<br />

to DNA-histone or histone subfractions. This staining pattern is frequently found in sera from<br />

patients receiving chronic treatment with procainamide, hydralazine, isoniazid, anticonvulsant<br />

drugs, and some environmental chemical agents.<br />

2. A peripheral (rim) pattern, which is attributed to antibody reacting with native DNA and<br />

soluble DNA-histone complexes. This staining pattern is frequently seen in sera from patients<br />

with systemic lupus erythematosus (>95 percent).<br />

3. Speckled FANA staining, which is usually attributed to antibodies reacting with saline-soluble<br />

antigens. These antibodies are directed to nonhistone antigens and include Sm, ribonucleoprotein,<br />

SS-A/Ro, SS-B/La, PM-1, and SCl-70. While these staining patterns frequently occur in<br />

patients with mixed connective tissue diseases, including Sjögren’s syndrome, polymyositis<br />

and progressive systemic sclerosis, they have also been found in sera from persons exposed to<br />

immunotoxic agents.<br />

4. The nucleolar staining pattern, which has been restricted to antibodies reactive with nucleolar<br />

RNA. This pattern is associated with a particular form of systemic sclerosis (progressive<br />

systemic sclerosis).<br />

10.5 TESTS FOR DETECTING IMMUNOTOXICITY IN ANIMAL MODELS<br />

For most chemicals, an assessment of their potential to produce immunotoxicity in humans is based<br />

on testing in animals. Many of the tests used in animal studies are the same as, or at least analogous<br />

to, those available for clinical assessment described above. However, studies in animals offer the

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!